Controlled release of enrofloxacin by vanillin-crosslinked chitosan-polyvinyl alcohol blends
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
34082942
DOI
10.1016/j.msec.2021.112125
PII: S0928-4931(21)00264-2
Knihovny.cz E-zdroje
- Klíčová slova
- Chitosan, Controlled drug release, Crosslinking, Drug-polymer solubility, Solvent casting, Transdermal delivery, Vanillin,
- MeSH
- benzaldehydy MeSH
- chitosan * MeSH
- enrofloxacin MeSH
- léky s prodlouženým účinkem MeSH
- polyvinylalkohol * MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- benzaldehydy MeSH
- chitosan * MeSH
- enrofloxacin MeSH
- léky s prodlouženým účinkem MeSH
- polyvinylalkohol * MeSH
- vanillin MeSH Prohlížeč
In transdermal drug delivery applications uniform drug distribution and sustained release are of great importance to decrease the side effects. In this direction in the present research, vanillin crosslinked chitosan (CS) and polyvinyl alcohol (PVA) blend based matrix-type transdermal system was prepared by casting and drying of aqueous solutions for local delivery of enrofloxacin (ENR) drug. Subsequently, the properties including the morphology, chemical structure, thermal behavior, tensile strength, crosslinking degree, weight uniformity, thickness, swelling and drug release of the CS-PVA blend films before and after crosslinking were characterized. In vitro drug release profiles showed the sustained release of ENR by the incorporation of vanillin as a crosslinker into the CS-PVA polymer matrix. Furthermore, the release kinetic profiles revealed that the followed mechanism for all samples was Higuchi and the increase of vanillin concentration in the blend films resulted in the change of diffusion mechanism from anomalous transport to Fickian diffusion. Overall, the obtained results suggest that the investigated vanillin crosslinked CS-PVA matrix-type films are potential candidates for transdermal drug delivery system.
Citace poskytuje Crossref.org